CanBas Co.,Ltd. — Investor Relations & Filings
CanBas is a clinical-stage biopharmaceutical company dedicated to the research and development of novel therapeutics for cancer patients. The company focuses on drug discovery in the field of oncology, including immuno-oncology and treatments targeting the cell cycle. Its pipeline includes CBP501, a calmodulin-modulating peptide that has undergone Phase II clinical trials. CanBas leverages proprietary screening systems and core technologies to develop innovative anti-cancer agents, with a focus on creating treatments with potentially fewer side effects.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 確認書 | 2025-09-29 | Japanese | |
| 有価証券報告書-第26期(2024/07/01-2025/06/30) | 2025-09-29 | Japanese | |
| 確認書 | 2025-02-13 | Japanese | |
| 半期報告書-第26期(2024/07/01-2025/06/30) | 2025-02-13 | Japanese | |
| 臨時報告書 | 2024-09-30 | Japanese | |
| 内部統制報告書-第25期(2023/07/01-2024/06/30) | 2024-09-27 | Japanese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
4 filings
| |||||
| 7936822 | 確認書 | 2025-09-29 | Japanese | ||
| 7936821 | 有価証券報告書-第26期(2024/07/01-2025/06/30) | 2025-09-29 | Japanese | ||
| 7277568 | 確認書 | 2025-02-13 | Japanese | ||
| 7277570 | 半期報告書-第26期(2024/07/01-2025/06/30) | 2025-02-13 | Japanese | ||
|
2024
8 filings
| |||||
| 7306965 | 臨時報告書 | 2024-09-30 | Japanese | ||
| 7307431 | 内部統制報告書-第25期(2023/07/01-2024/06/30) | 2024-09-27 | Japanese | ||
| 7307422 | 確認書 | 2024-09-27 | Japanese | ||
| 7307425 | 有価証券報告書-第25期(2023/07/01-2024/06/30) | 2024-09-27 | Japanese | ||
| 7339431 | 確認書 | 2024-05-10 | Japanese | ||
| 7339419 | 四半期報告書-第25期第3四半期(2024/01/01-2024/03/31) | 2024-05-10 | Japanese | ||
| 7357384 | 確認書 | 2024-02-09 | Japanese | ||
| 7357385 | 四半期報告書-第25期第2四半期(2023/10/01-2023/12/31) | 2024-02-09 | Japanese | ||
|
2023
3 filings
| |||||
| 7539934 | 確認書 | 2023-11-10 | Japanese | ||
| 7539886 | 四半期報告書-第25期第1四半期(2023/07/01-2023/09/30) | 2023-11-10 | Japanese | ||
| 7544102 | 臨時報告書 | 2023-09-27 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AnorMED Inc.
Developed small molecule therapeutics for serious diseases,…
|
— | CA | Professional, scientific and te… |
|
ANTEOTECH LTD
Develops nanoglue technology for life sciences and lithium-…
|
ADO | AU | Professional, scientific and te… |
|
Anthem Biosciences Limited
Integrated CRAMS organization for drug discovery, developme…
|
ANTHEM | IN | Professional, scientific and te… |
|
APPLIED DNA SCIENCES INC
Develops and manufactures DNA-based technologies for geneti…
|
APDN | US | Professional, scientific and te… |
|
Aprea Therapeutics, Inc.
Clinical-stage biopharma developing cancer therapeutics via…
|
APRE | US | Professional, scientific and te… |
|
AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases…
|
397030 | KR | Professional, scientific and te… |
|
Aptahem AB
A clinical-stage biotech developing aptamer-based drugs for…
|
APTA | SE | Professional, scientific and te… |
|
APTAMER GROUP PLC
Develops custom affinity binders for research, diagnostics,…
|
APTA | GB | Professional, scientific and te… |
|
Aptevo Therapeutics Inc.
Clinical-stage biotech developing antibody-based immunother…
|
APVO | US | Professional, scientific and te… |
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
CanBas Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13588/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13588 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13588 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13588 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13588}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CanBas Co.,Ltd. (id: 13588)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.